John Valliant, Chief Executive Officer at Fusion Pharmaceuticals Inc. (FUSN), sold 10,300 shares at $7.55 ($78K) on 2022-03-28, disclosed to the SEC on 2022-03-29.
Open-market sale of $78k FUSN by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.42 | 500 | $4K | 4.8% |
| 2 | $7.55 | 9,600 | $72K | 93.3% |
| 3 | $7.52 | 200 | $2K | 1.9% |
| Total | $7.54 avg | 10,300 | $78K | 100% |
| Filing → |
| FUSN | SELL | 2022-04-13 | $432K | — | Filing → |
| FUSN | SELL | 2022-04-08 | $16K | — | Filing → |
| FUSN | SELL | 2022-04-05 | $29K | — | Filing → |